CalciMedica (CALC) Institutional Ownership → Biden replacement revealed? (From Paradigm Press) (Ad) Free CALC Stock Alerts $5.70 -0.03 (-0.52%) (As of 12:30 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for CalciMedica (NASDAQ:CALC)Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.17MNumber ofInstitutional Sellers(last 12 months)0 Get CALC Insider Trade Alerts Want to know when executives and insiders are buying or selling CalciMedica stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CALC Institutional Buying and Selling by Quarter Ad Porter & CompanyThe biggest energy story ever? Discover why I’m calling this one of the biggest developments in the global energy market since the shale revolution… why everything you’ve ever been told about Trump’s environmental record is a lie…For the full story, click here. CalciMedica Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/23/2024 BML Capital Management LLC160,424$667K0.4%+10.3%1.494% 2/2/2024 Meritage Portfolio Management46,000$132K0.0%+360.0%0.810% 1/30/2024 BML Capital Management LLC145,424$416K0.3%+63.8%2.560% 12/7/2023Hudson Bay Capital Management LP166,857$432K0.0%N/A2.938% 7/31/2023 Meritage Portfolio Management10,000$40K0.0%N/A0.177% 7/24/2023 BML Capital Management LLC88,781$356K0.3%N/A1.568% (Data available from 1/1/2016 forward) CALC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CALC shares? During the previous two years, the following institutional investors and hedge funds held shares of CalciMedica shares: BML Capital Management LLC ($667K), and Hudson Bay Capital Management LP ($432K), Meritage Portfolio Management ($132K).Learn more on CALC's institutional investors. Which institutional investors have been buying CalciMedica stock? The following institutional investors have purchased CalciMedica stock in the last 24 months: Hudson Bay Capital Management LP ($166.86K), BML Capital Management LLC ($160.42K), and Meritage Portfolio Management ($46K). How much institutional buying is happening at CalciMedica? Institutional investors have bought a total of 373,281 shares in the last 24 months. This purchase volume represents approximately $1.17M in transactions. Related Companies: Immuneering Major Shareholders BioLineRx Major Shareholders Checkpoint Therapeutics Major Shareholders Aadi Bioscience Major Shareholders Eledon Pharmaceuticals Major Shareholders Rockwell Medical Major Shareholders Homology Medicines Major Shareholders Gain Therapeutics Major Shareholders Clene Major Shareholders Apollomics Major Shareholders This page (NASDAQ:CALC) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Report😱 This phenomenon is smashing regular market gainsMillPubForget Nvidia. This is the future of AIPorter & CompanyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalciMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
